Literature DB >> 17966593

[The evaluation of selected oxidative stress parameters in patients with hyperthyroidism].

Grzegorz Andryskowski1, Tomasz Owczarek.   

Abstract

INTRODUCTION: Hyperthyroidism induces the acceleration of the basic metabolism and increases cellular oxygen utilization, consequently intensifies reactive oxygen species production and disturbs the oxidant-antioxidant balance.
OBJECTIVES: The objective of this study was to evaluate the selected oxidative stress parameters in patients with hyperthyroidism by analysis of the reactive oxygen species neutralizing enzymes activity--superoxide dismutase (SOD), glutathione peroxidase (GSHPx) and catalase (CAT), the estimation of free radical processes intensity--concentration of malondialdehyde (MDA), sulfhydryl groups (SH) in proteins and by quantification of the serum total antioxidant status (TAS). PATIENTS AND
METHOD: . Twenty-seven patients treated for hyperthyroidism and 12 healthy individuals were enrolled in the study. Enzyme activity (SOD, GSHPx, CAT), MDA and concentration of SH groups were analysed in erythrocytes, while TAS was measured in serum.
RESULTS: Patients with hyperthyroidism compared with healthy subjects were characterized by a higher GSHPx activity in erythrocytes, lower serum TAS, the lower content of SH groups in proteins and the lower MDA concentration in erythrocytes.
CONCLUSIONS: Our results suggest that hyperthyroidism increases oxidative stress and disturbs oxidant-antioxidant balance in the body. Thyreostatic treatment, if not leads to whole metabolic compensation, may only reduce oxidant-antioxidant disorders, however is not able to eliminate them entirely.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17966593

Source DB:  PubMed          Journal:  Pol Arch Med Wewn


  7 in total

1.  Oxidative stress: a new risk factor for thyroid cancer.

Authors:  Mingzhao Xing
Journal:  Endocr Relat Cancer       Date:  2012-01-09       Impact factor: 5.678

Review 2.  Recent insights into the cell biology of thyroid angiofollicular units.

Authors:  Ides M Colin; Jean-François Denef; Benoit Lengelé; Marie-Christine Many; Anne-Catherine Gérard
Journal:  Endocr Rev       Date:  2013-01-24       Impact factor: 19.871

3.  Erythrocyte osmotic fragility and lipid peroxidation in experimental hyperthyroidism.

Authors:  Rıfat Yücel; Semra Ozdemir; Nuran Darıyerli; Selmin Toplan; M Can Akyolcu; Günnur Yiğit
Journal:  Endocrine       Date:  2009-10-23       Impact factor: 3.633

4.  Total oxidant/antioxidant status in sera of patients with thyroid cancers.

Authors:  Dong Wang; Jia-Fu Feng; Ping Zeng; Yun-Hong Yang; Jun Luo; Yu-Wei Yang
Journal:  Endocr Relat Cancer       Date:  2011-12-01       Impact factor: 5.678

5.  Analyses of antioxidant status and nucleotide alterations in genes encoding antioxidant enzymes in patients with benign and malignant thyroid disorders.

Authors:  Nur Siti Fatimah Ramli; Sarni Mat Junit; Ng Khoon Leong; Nurhanani Razali; Jaime Jacqueline Jayapalan; Azlina Abdul Aziz
Journal:  PeerJ       Date:  2017-06-01       Impact factor: 2.984

6.  Thyroid function and non-alcoholic fatty liver disease in hyperthyroidism patients.

Authors:  Bairong Wang; Baomin Wang; Yumei Yang; Jing Xu; Mengyang Hong; Mingfeng Xia; Xiaomu Li; Xin Gao
Journal:  BMC Endocr Disord       Date:  2021-02-18       Impact factor: 2.763

7.  Measurement of oxidative stress and total antioxidant capacity in hyperthyroid patients following treatment with carbimazole and antioxidant.

Authors:  Dr Razia Sultana; Ara Dr Shahin; Haque Md Jawadul
Journal:  Heliyon       Date:  2021-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.